| Kathryn S Newport, MD | |
|
5602 Sw Lee Blvd, Lawton, OK 73505-9635 | |
| (580) 531-4700 | |
| (580) 531-6477 |
| Full Name | Kathryn S Newport |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Experience | 37 Years |
| Location | 5602 Sw Lee Blvd, Lawton, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194717769 | NPI | - | NPPES |
| 100090180A | Medicaid | OK | |
| 731044914045 | Other | BCBS OF OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 16467 (Oklahoma) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Agape Anesthesia Crna Pllc | 7214365014 | 10 |
News Archive
A study of immune-deficient adults and children has shown that patients who fail to respond positively to infections and vaccinations have robust humoral immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) structural proteins.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that it has held an end-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) to seek consensus on clinical program scope and endpoints for licensure of PV-10 for metastatic melanoma. The meeting was held at the Agency's White Oak Campus in Silver Spring, MD.
The Children's Hospital of Philadelphia and Temple University have received a joint $4.3 million, four-year grant from the National Institute of Mental Health to investigate new methods to eradicate HIV that lurks in brain cells despite conventional antiviral treatments.
Insomnia affects up to a quarter of the population in Australia and can have a severe impact on the quality of life and health of long term chronic sufferers, who often cannot stay alert enough to remain in the workforce.
› Verified 4 days ago
| Entity Name | Southwestern Physician Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083640601 PECOS PAC ID: 6305937772 Enrollment ID: O20070814000680 |
News Archive
A study of immune-deficient adults and children has shown that patients who fail to respond positively to infections and vaccinations have robust humoral immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) structural proteins.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that it has held an end-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) to seek consensus on clinical program scope and endpoints for licensure of PV-10 for metastatic melanoma. The meeting was held at the Agency's White Oak Campus in Silver Spring, MD.
The Children's Hospital of Philadelphia and Temple University have received a joint $4.3 million, four-year grant from the National Institute of Mental Health to investigate new methods to eradicate HIV that lurks in brain cells despite conventional antiviral treatments.
Insomnia affects up to a quarter of the population in Australia and can have a severe impact on the quality of life and health of long term chronic sufferers, who often cannot stay alert enough to remain in the workforce.
› Verified 4 days ago
| Entity Name | Northstar Anesthesia Of Oklahoma, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043516628 PECOS PAC ID: 1254519275 Enrollment ID: O20110622000357 |
News Archive
A study of immune-deficient adults and children has shown that patients who fail to respond positively to infections and vaccinations have robust humoral immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) structural proteins.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that it has held an end-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) to seek consensus on clinical program scope and endpoints for licensure of PV-10 for metastatic melanoma. The meeting was held at the Agency's White Oak Campus in Silver Spring, MD.
The Children's Hospital of Philadelphia and Temple University have received a joint $4.3 million, four-year grant from the National Institute of Mental Health to investigate new methods to eradicate HIV that lurks in brain cells despite conventional antiviral treatments.
Insomnia affects up to a quarter of the population in Australia and can have a severe impact on the quality of life and health of long term chronic sufferers, who often cannot stay alert enough to remain in the workforce.
› Verified 4 days ago
| Entity Name | J J Young |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033221122 PECOS PAC ID: 7517126105 Enrollment ID: O20120319000293 |
News Archive
A study of immune-deficient adults and children has shown that patients who fail to respond positively to infections and vaccinations have robust humoral immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) structural proteins.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that it has held an end-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) to seek consensus on clinical program scope and endpoints for licensure of PV-10 for metastatic melanoma. The meeting was held at the Agency's White Oak Campus in Silver Spring, MD.
The Children's Hospital of Philadelphia and Temple University have received a joint $4.3 million, four-year grant from the National Institute of Mental Health to investigate new methods to eradicate HIV that lurks in brain cells despite conventional antiviral treatments.
Insomnia affects up to a quarter of the population in Australia and can have a severe impact on the quality of life and health of long term chronic sufferers, who often cannot stay alert enough to remain in the workforce.
› Verified 4 days ago
| Entity Name | Southwestern Oklahoma Surgical Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1841952397 PECOS PAC ID: 9830589738 Enrollment ID: O20211208002761 |
News Archive
A study of immune-deficient adults and children has shown that patients who fail to respond positively to infections and vaccinations have robust humoral immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) structural proteins.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that it has held an end-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) to seek consensus on clinical program scope and endpoints for licensure of PV-10 for metastatic melanoma. The meeting was held at the Agency's White Oak Campus in Silver Spring, MD.
The Children's Hospital of Philadelphia and Temple University have received a joint $4.3 million, four-year grant from the National Institute of Mental Health to investigate new methods to eradicate HIV that lurks in brain cells despite conventional antiviral treatments.
Insomnia affects up to a quarter of the population in Australia and can have a severe impact on the quality of life and health of long term chronic sufferers, who often cannot stay alert enough to remain in the workforce.
› Verified 4 days ago
| Entity Name | Agape Anesthesia Crna Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346871480 PECOS PAC ID: 7214365014 Enrollment ID: O20220502000777 |
News Archive
A study of immune-deficient adults and children has shown that patients who fail to respond positively to infections and vaccinations have robust humoral immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) structural proteins.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that it has held an end-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) to seek consensus on clinical program scope and endpoints for licensure of PV-10 for metastatic melanoma. The meeting was held at the Agency's White Oak Campus in Silver Spring, MD.
The Children's Hospital of Philadelphia and Temple University have received a joint $4.3 million, four-year grant from the National Institute of Mental Health to investigate new methods to eradicate HIV that lurks in brain cells despite conventional antiviral treatments.
Insomnia affects up to a quarter of the population in Australia and can have a severe impact on the quality of life and health of long term chronic sufferers, who often cannot stay alert enough to remain in the workforce.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kathryn S Newport, MD Po Box 840807, Dallas, TX 75284-0807 Ph: (580) 531-4700 | Kathryn S Newport, MD 5602 Sw Lee Blvd, Lawton, OK 73505-9635 Ph: (580) 531-4700 |
News Archive
A study of immune-deficient adults and children has shown that patients who fail to respond positively to infections and vaccinations have robust humoral immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) structural proteins.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that it has held an end-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) to seek consensus on clinical program scope and endpoints for licensure of PV-10 for metastatic melanoma. The meeting was held at the Agency's White Oak Campus in Silver Spring, MD.
The Children's Hospital of Philadelphia and Temple University have received a joint $4.3 million, four-year grant from the National Institute of Mental Health to investigate new methods to eradicate HIV that lurks in brain cells despite conventional antiviral treatments.
Insomnia affects up to a quarter of the population in Australia and can have a severe impact on the quality of life and health of long term chronic sufferers, who often cannot stay alert enough to remain in the workforce.
› Verified 4 days ago
Dr. Oksana I Martsinkevich, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3401 W Gore Blvd, Lawton, OK 73505 Phone: 580-531-8687 | |
Dr. Kanchan Lal Lodhia, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 225 Nw Mockingbird Rd, Lawton, OK 73507 Phone: 580-250-0789 Fax: 580-458-2458 | |
Dr. Beatrice S Christopher, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 1515 Ne Lawrie Tatum Rd, Lawton, OK 73507 Phone: 580-354-5000 | |
Charles E Mortensen, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 3401 W Gore Blvd, Lawton, OK 73505 Phone: 580-355-8620 Fax: 580-357-3277 | |
Handel F Pascoe, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3401 W Gore Blvd, Lawton, OK 73505 Phone: 580-355-8620 Fax: 580-357-3277 | |
Richard Eric Johnson, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 3401 W Gore Blvd, Department Of Anesthesiology, Lawton, OK 73502 Phone: 580-355-8620 Fax: 580-536-2292 |